Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Hospira Reports Third-Quarter 2011 Results
Date:10/26/2011
p>
277.0234.5Cash Flow From Investing Activities: Capital expenditures (including instruments placed with or leased to customers)
(211.3)(141.8) Acquisitions, net of cash acquired
-(541.8) Purchases of intangibles and other investments
(5.2)(11.9) Proceeds from disposition of businesses and assets
13.362.6Net Cash Used in Investing Activities
(203.2)(632.9)Cash Flow From Financing Activities: Issuance of long-term debt, net of fees paid
-492.5 Other borrowings, net
8.5(0.3) Common stock repurchased
(200.0)(50.0) Excess tax benefit from stock-based compensation arrangements
7.419.3 Proceeds from stock options exercised
47.5133.7Net Cash (Used in) Provided by Financing Activities
(136.6)595.2Effect of exchange rate changes on cash and cash equivalents
(14.1)6.7Net change in cash and cash equivalents
(76.9)203.5Cash and cash equivalents at beginning of period
604.3946.0Cash and cash equivalents at end of period
$
527.4$
,149.5Supplemental Cash Flow Information:Cash paid during the period- Interest
$
82.4$
80.8 Income taxes, net of refunds
$
34.0$
3.7 Non-cash financing activities- Provision on the early debt extinguishment incurred but not paid
$
-$
36.8Hospira, Inc.Net Sales by Product Line(Unaudited)(dollars in millions)Three Months Ended September 30,Nine Months Ended September 30,20112010% Change at
Actual Currency
Rates% Change at
Constant Currency
Rates (1)20112010% Change at
Actual Currency
Rates% Change at
Constant Currency
Rates (1)Americas-- Specialty Injectable Pharmaceuticals
$ 485.2$ 433.412.0%11.3%$ 1,525.2$ 1,370.311.3%1
'/>"/>
| SOURCE Hospira, Inc. Copyright©2010 PR Newswire. All rights reserved |
Related medicine technology :
1. Hospira Announces Certain Preliminary Third-Quarter 2011 Results
2. Hospira to Host Conference Call for Third-Quarter 2011 Results
3. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
4. Hospira to Host 2011 Investor Day
5. Hospira to Present at the Morgan Stanley Global Healthcare Conference
6. Hospira Expands Board of Directors
7. Hospira Announces U.S. Approval of Solution Version of Gemcitabine Injection
8. Hospira Reports Second-Quarter 2011 Results
9. Hospira to Host Conference Call for Second-Quarter 2011 Results
10. Hospira Receives Health Canada Regulatory Approval for Symbiq™ Infusion System Software Upgrade
11. Hospira to Present at the Sanford C. Bernstein Twenty-Seventh Annual Strategic Decisions Conference 2011
Post Your Comments:
(Date:6/18/2013)... Australia And EMERYVILLE, Calif. ... Pharmaceuticals, Inc. presented final results today from a ... extended release) capsules demonstrating a statistically significant improvement ... from baseline at week 8 versus placebo in ... Adamas, investigational extended-release formulation of amantadine intended for ...
(Date:6/18/2013)... BASKING RIDGE, N.J. , June 18, 2013 /PRNewswire/ ... Adrian Peterson and professional family expert ... are partnering with Mylan Specialty L.P., the fully integrated ... MYL ), to raise awareness of this significant health ... of the U.S. Food and Drug Administration (FDA) approval ...
(Date:6/18/2013)... 18, 2013 Polymer Technology Systems, Inc. ... Health Group to integrate the CardioChek ® ... administered by health systems across the country. The ... and distributed through Hanson Medical Systems , ... cholesterol, LDL cholesterol, triglycerides, and glucose. ...
Breaking Medicine Technology:Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 2Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 3Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 4Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 5Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 6Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 7Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 8Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3[0] Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease[0] Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign[0] Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients
... , CHADDS FORD, Pa. , Aug. 6 Endo Pharmaceuticals ... at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference on ... executive vice president and chief financial officer of Endo, will review the company,s ... , ...
... ,, WEIFANG, Shandong , ... Shengtai,Pharmaceutical, Inc. (OTC Bulletin Board: ... , Weifang Shengtai Pharmaceutical Co., Ltd ("Weifang Shengtai"), its,operating ... with Jiangsu Zongheng,Drying Equipment Co., Ltd. ("Jiangsu Zongheng") to ...
Cached Medicine Technology:Endo to Present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference 2Weifang Shengtai Purchased MVR Evaporator for Energy and Cost Saving 2Weifang Shengtai Purchased MVR Evaporator for Energy and Cost Saving 3Weifang Shengtai Purchased MVR Evaporator for Energy and Cost Saving 4(Date:6/18/2013)... VA (PRWEB) June 18, 2013 As obesity ... increase in need for surgical equipment during childbirth comes as ... child from within the mother when she is unable to ... deliveries, they are associated with higher rates of complication for ... to being harmful to the mother and child, forceps births ...
(Date:6/18/2013)... York (PRWEB) June 18, 2013 ... to protecting the rights of victims injured by defective ... independent review of Medtronic’s Infuse bone graft products are ... Medicine, a medical journal, the two studies serve up ... in effectiveness” when comparing Infuse and the traditional bone ...
(Date:6/18/2013)... New York, NY (PRWEB) June 18, 2013 ... M2a Magnum hip continue to move forward in a ... Indiana, Bernstein Liebhard LLP reports. According to court ... on June 17th, at which time the Court also ... scientific and technical issues pertinent to the Biomet hip ...
(Date:6/18/2013)... cancer cells have a much different and more ... The University of Texas at Dallas have found that ... combat lung cancer. , In an article published online ... UT Dallas researchers compared the metabolic characteristics of non-small-cell ... the same patient. , They found that the ...
(Date:6/18/2013)... More than 1.1 million people in the ... to the Centers for Disease Control and Prevention (CDC). Of ... support of National HIV Testing Day on June 27, Allsup, ... (SSDI) representation, the CDC and other organizations are raising awareness ... reports about 50,000 new HIV infections each year. Along with ...
Breaking Medicine News(10 mins):Health News:Forceps Births Double, Obesity is Major Reason in Births Complications 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 3Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 2Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 3Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:Allsup Observes National HIV Testing Day June 27 2Health News:Allsup Observes National HIV Testing Day June 27 3[0] Forceps Births Double, Obesity is Major Reason in Births Complications[0] Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments[0] Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation[0] UT Dallas study suggests new approach to fight lung cancer[0] Allsup Observes National HIV Testing Day June 27
... has shown that too much heat can decrease sperm count, and ... the Bourn Hall Clinic in Cambridgeshire have suggested that soaking up ... for fathering a child. ,Many couples believe that a ... loosen up fully. ,However, sperm takes eight weeks ...
... of an estimated one in 20,000 newborns are shocked to ... a progressive and crippling genetic disorder. Although doctors know ... are available, many children are not diagnosed until they are ... have type 1 myotonic dystrophy (DM1) a common form ...
... pet food, then tooth paste and now fish. There just seems ... ,Only two days ago the US put on hold ... its finding on whether it contains diethylene glycol, a chemical commonly ... is warning that packages of fish imported from China into the ...
... pay for badly needed restorations, are reaching out to the ... bird-watching lectures, Sunday jazz concerts, brunches with star chefs, Halloween ... ,The cemetery tourism fever is catching on. ... Titanic made many gasp for breath. It looked as if ...
... the time of Chaucer were not dwarfs but only short ... was the case with women more or less, a new ... revealed. ,As part of their study, scientists researched ... upon Humber, North East Lincolnshire, and found that the average ...
... has found that smokers who have a say in how ... and are more successful. ,The study, which ... of human motivation, was conducted by a team of researchers ... ,The crux of Self-Determination Theory is that a ...
Cached Medicine News:Health News:Researcher Studying Disease That Cripples Newborns 2Health News:US Consumers Warned Against Toxic Chinese Fish 2Health News:Cemetery Tourism, the New Catchword in US 2Health News:Our Medieval Ancestors Were More or Less Similar to Us Than Previously Thought 2Health News:Smokers Who Have a Say in How They Quit More Likely to Kick the Habit 2Sun Bathing Reduces Sperm CountResearcher Studying Disease That Cripples NewbornsUS Consumers Warned Against Toxic Chinese FishCemetery Tourism, the New Catchword in USOur Medieval Ancestors Were More or Less Similar to Us Than Previously ThoughtSmokers Who Have a Say in How They Quit More Likely to Kick the Habit
... designed specifically for the Palm Organizers ... ward rounds. It is intended to ... consultations that are requested by the ... Ward round examinations and to record ...
... tracking and billing. This ... Handheld application, a complete ... CPT™ and ICD-9-CM codes ... Designed for any medical ...
In addition to the patient data OB-on-Call contains a comprehensive Medications list displaying related drugs by brand name, generic title, and usage description notes....
Archimedes is an innovative specialty calculator. Forget having to remember complicated formulas, just enter the values and out come the results....
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |